23 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase.
Imperial College
Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase.
Imperial College
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis.
University of Dundee
Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors.
Imperial College
Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase.
Imperial College
Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.
Imperial College
Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode.
Imperial College
Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase.
G. D. Searle Research and Development
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.
University of Dundee
Derivatives of aryl amines containing the cytotoxic 1,4-dioxo-2-butenyl pharmacophore.
Acadia University
A chiral recognition element with an unusual size constraint affects the potency and selectivity for peptidomimetic inhibitors of Candida albicans myristoyl-CoA:protein N-myristoyltransferase
TBA
3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors.
Second Military Medical University
How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using
Johannes Gutenberg-Universit£T Mainz
Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase.
G.D. Searle And
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors.
University of Dundee
Emerging New Targets for the Treatment of Resistant Fungal Infections.
Second Military Medical University
Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.
University of Dundee